G-Protein Coupled Receptors Market Report: Size, Growth and Outlook
According to Shivani Zoting, who specializes in biotechnology, pharmaceutical research, and life sciences, with 5+ years of experience in market research and industry analysis, the G-Protein Coupled Receptors (GPCR) market is set to grow from USD 4.27 billion in 2026 to USD 6.70 billion by 2035, driven by sustained investment in drug discovery, precision medicine, and GPCR-targeted therapeutics. Her research identifies cell lines, cAMP functional assays, and cancer research as the leading market segments, while North America remains the largest regional market and Asia Pacific is expected to record the fastest growth. The analysis also highlights the competitive strategies of major companies, including Thermo Fisher Scientific, Eurofins Scientific, QIAGEN, WuXi AppTec, Promega Corporation, Merck KGaA, and BD, which continue to advance innovation across GPCR research and drug development.
Last Updated : 01 July 2026
Category: Therapeutic Area
Insight Code: 5378
Format: PDF / PPT / Excel